ARN-509

0 reviews Write a review

Product Code: 3034
Availability: In Stock

$335.00

MG Options

Qty

ARN-509 is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM, useful for prostate cancer treatment. Phase 2.

Chemical Name Benzamide, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl-

Biological Activity:
Biological Activity	ARN-509 is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM, useful for prostate cancer treatment. Phase 2.
Technical Data:
M.W.	477.43
Formula:	<h1> C<sub>21</sub>H<sub>15</sub>F<sub>4</sub>N<sub>5</sub>O<sub>2</sub>S</h1>
Solubility:	DMSO
Purity:	98%
Storage:	-20℃
CAS No:	956104-40-8

Write a review

Your Name

Your Review Note: HTML is not translated!

Rating Bad Good

Continue

About HDH PHARMA

At HDH Pharma, we are committed to offering our clients the highest quality research services with the most convenient and effective communications from both US and Indian operations. Clients in the Americas and Europe can pick up the phone and speak directly with our scientists in the US. Clients in Asia can receive the same rapid response from our scientists in India. HDH’s hybrid operation is designed with our client’s operational needs in mind.

ARN-509

Write a review

About HDH PHARMA

Information

Extras

My Account